The Reduction of Uromodulin, Complement Factor H, and Their Interaction Is Associated with Acute Kidney Injury to Chronic Kidney Disease Transition in a Four-Time Cisplatin-Injected Rat Model
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24076636 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Zheyu Xing und 3 weiteren Autor:innen. Beteiligte Einrichtung: Renal Division, Peking University First Hospital, Beijing 100034, China. Hauptthemen laut MEDLINE: Acute Kidney Injury, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Uromodulin is recognized as a protective factor during AKI-to-CKD progression, but the mechanism remains unclear. We previously reported that uromodulin interacts with complement factor H (CFH) in vitro, and currently aimed to study the expression and interaction evolution of uromodulin and CFH during AKI-to-CKD transition. We successfully established a rat model of AKI-to-CKD transition induced by a four-time cisplatin treatment. The blood levels of BUN, SCR, KIM-1 and NGAL increased significantly during the acute injury phase and exhibited an uptrend in chronic progression. PAS staining showed the nephrotoxic effects of four-time cisplatin injection on renal tubules, and Sirius red highlighted the increasing collagen fiber. Protein and mRNA levels of uromodulin decreased while urine levels increased in acute renal injury on chronic background. An extremely diminished level of uromodulin correlated with severe renal fibrosis. RNA sequencing revealed an upregulation of the alternative pathway in the acute stage. Renal CFH gene expression showed an upward tendency, while blood CFH localized less, decreasing the abundance of CFH in kidney and following sustained C3 deposition. A co-IP assay detected the linkage between uromodulin and CFH. In the model of AKI-to-CKD transition, the levels of uromodulin and CFH decreased, which correlated with kidney dysfunction and fibrosis. The interaction between uromodulin and CFH might participate in AKI-to-CKD transition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Renal Division, Peking University First Hospital, Beijing 100034, China.
- Institute of Nephrology, Peking University, Beijing 100034, China.
- Key Laboratory of Renal Disease, Ministry of Health of China, Beijing 100034, China.
- Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing 100034, China.
ORCID-Profile: Yuqing Chen
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xing, Z., Gong, K., Hu, N., & Chen, Y. (2023). The Reduction of Uromodulin, Complement Factor H, and Their Interaction Is Associated with Acute Kidney Injury to Chronic Kidney Disease Transition in a Four-Time Cisplatin-Injected Rat Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24076636
Vancouver
Xing Z, Gong K, Hu N, Chen Y. The Reduction of Uromodulin, Complement Factor H, and Their Interaction Is Associated with Acute Kidney Injury to Chronic Kidney Disease Transition in a Four-Time Cisplatin-Injected Rat Model. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24076636
BibTeX
@article{Xing2023,
author = {Xing, Zheyu and Gong, Kunjing and Hu, Nan and Chen, Yuqing},
title = {The Reduction of Uromodulin, Complement Factor H, and Their Interaction Is Associated with Acute Kidney Injury to Chronic Kidney Disease Transition in a Four-Time Cisplatin-Injected Rat Model},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24076636}
}
EUVIMED